Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1161 of 5804
-
Digital twin tech could predict aortic rupture risk
Knowledge-focused Recruiting nowAortic dissection causes a tear in the inner layers of the aorta, leading to the formation of a true and false lumen. There are two types of dissection: type A, which affects the ascending aorta, and type B, which affects the descending aorta. Type A aortic dissection is almost …
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Can mindfulness ease serious mental illness? new study aims to find out
Symptom relief ENROLLING_BY_INVITATIONSerious mental illness (SMI), encompassing schizophrenia-spectrum and major mood disorders, has been estimated to affect approximately 5.4% of the U.S. adult population each year. Research shows low rates of evidence-based treatment being provided to patients with SMI. This is un…
Phase: NA • Sponsor: Butler Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Acupuncture with electricity may help men stop leaking after prostate removal
Symptom relief Not yet recruitingThis clinical trial aims to find out if early electroacupuncture (EA) helps people recover the ability to control urination and is safe after surgery to remove the prostate gland for prostate cancer (radical prostatectomy). Participants are people aged 18 to 80 with localized pr…
Phase: NA • Sponsor: Shanghai University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Taurine supplement may soothe radiation burns
Symptom relief Recruiting nowThis is a single-center, double-blind, randomized controlled study. The patients were divided into control group and experimental group, 80 cases each. From the first day of radiotherapy to the end of radiotherapy, the experimental group was treated with 24 grams of taurine granu…
Phase: PHASE2 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Smartwatch study aims to stop muscle loss in GLP-1 users
Prevention Recruiting nowThe goal of this study is to learn if a smartwatch that measures activity level and body composition, combined with exercise reminders, can safely improve strength and muscle mass in people who recently started or are planning to start treatment with incretin therapy (liraglutide…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:07 UTC
-
New IVIG treatment aims to boost platelets in ITP patients
Disease control Recruiting nowIt is a clinical trial of a medicinal product Human Immunoglobulin for Intravenous Injection (5%) manufactured by Grand Shuyang Life Sciences (Chengdu) Co., Ltd. (hereinafter referred to as 5% IVIG). This clinical study is conducted to evaluate the efficacy and safety of 5% IVIG …
Phase: PHASE3 • Sponsor: Grand Shuyang Life Sciences (Chengdu) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Birth control IUD could treat Pre-Cancer uterine condition
Disease control TerminatedResearchers are looking for a better way to treat women with nonatypical endometrial hyperplasia (NAEH). Endometrial hyperplasia is a condition where the lining of the uterus (called the endometrium) becomes too thick. Nonatypical means that the condition is not cancerous. It is…
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New brain zapping method may lift depression better than standard approach
Symptom relief ENROLLING_BY_INVITATIONThis study compares two types of non-invasive brain stimulation to treat major depression in patients who have not found relief from at least one antidepressant medication. The study will use a specific type of brain stimulation called prolonged intermittent Theta Burst Stimulat…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New drug cocktail aims to ease dual Heart-Lung condition
Disease control Recruiting nowThis clinical trial will evaluate whether combination therapy with Dapagliflozin + Macitentan improves outcomes compared to Dapagliflozin + placebo in patients with combined pre- and post-capillary pulmonary hypertension (CpcPH). The study will measure changes in pulmonary vascu…
Phase: PHASE4 • Sponsor: Gachon University Gil Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New shot aims to keep bipolar symptoms at bay longer
Disease control Recruiting nowThe purpose of this study is to assess the efficacy and safety of brenipatide when administered with standard of care (SoC), compared with placebo plus SoC in delaying the worsening of bipolar disorder symptoms. The trial is divided into three periods as follows: Screening perio…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Blood test could spot lingering cancer after colon surgery
Diagnosis Not yet recruitingThis observational study aims to evaluate the predictive performance of various omics-based methods for detecting minimal residual disease (MRD) in stage III colorectal cancer. The study involves the collection of blood samples from patients who have accepted surgery for colorect…
Sponsor: Sun Yat-sen University • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Blood test may outsmart PET scans in childhood cancer
Knowledge-focused Recruiting nowClassical Hodgkin lymphoma (cHL) accounts for 15% of all cases of cancer in children and adolescents and represents the first cause of cancer during adolescence. Combined multi-modal chemotherapy and modern radiation techniques have transformed cHL in a highly curable cancer. How…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Could a diet tame chronic hives in children?
Symptom relief ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn whether a histamine- and pseudoallergen-restricted diet can help reduce symptoms in people with chronic urticaria. It will also learn whether this diet changes the need for urticaria medication. The main questions it aims to answer are…
Phase: NA • Sponsor: Istanbul University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Radioactive drug takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[177Lu\]Lu-DFC413 and safety and imaging properties of \[68Ga\]Ga-NNS309 in patients aged ≥ 18 years with solid tumors
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Bone transport device aims to heal chronic leg ulcers
Disease control Recruiting nowThe TrueLok Elevate Transverse Bone Transport System is a modular external fixation device designed for transverse bone transport. It promotes local vascular and wound healing through controlled corticotomy and gradual distraction. The system is intended for adult patients with b…
Sponsor: Orthofix s.r.l. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Scientists deliberately infect volunteers with whooping cough to speed up vaccine research
Knowledge-focused Recruiting nowThe overall goal of this study is to establish a PRN-deficient pertussis Controlled Human Infection Model (CHIM) that represents currently circulating isolates, in the context of a North American exposure (vaccination and infection) pedigree.
Phase: PHASE1 • Sponsor: Dalhousie University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New stroke drug shows promise in early trial
Disease control Recruiting nowThis study is a multicenter, randomized, double-blind, parallel, placebo-controlled trial design to evaluate the efficacy and safety of the KPCXM18 injection at different doses for the treatment of acute ischemic stroke.
Phase: PHASE2 • Sponsor: Kunming Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New shot aims to tame lupus kidney flares
Disease control Recruiting nowThe study is a Phase II clinical trial to evaluate the efficacy and safety of SHR-2173 in patients with lupus nephritis (LN). It adopts a randomized, double-blind, placebo-controlled, multicenter trial design.
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Long-Term heart risks after rare COVID complication in kids under scrutiny
Knowledge-focused Recruiting nowMultisystem inflammatory syndrome in children (MIS-C) is a severe complication associated with SARS-CoV-2 infection that frequently affects the cardiovascular system. Although acute cardiac abnormalities usually resolve, the long-term cardiovascular consequences of MIS-C remain u…
Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New drug trial hopes to ease fragile x symptoms in boys and men
Symptom relief Recruiting nowThis study is a multicenter, double-blind, randomized, placebo-controlled study to assess the safety and tolerability of 3 doses of MRM-3379 in male participants with Fragile X Syndrome ages 16 to 45 (inclusive). In addition, a parallel cohort of participants ages 13 to \<16 will…
Phase: PHASE2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC